Diagnostic accuracy of Thyroid Imaging and Data System (TIRADS) ultrasound classification of thyroid nodules compared with cytological findings among patients in Tanzania.
Keywords:
Thyroid nodules; Ultrasound; ACR TI-RADS; Cytology; Diagnostic accuracy; TanzaniaAbstract
Background: Thyroid nodules (TNs) are common worldwide, particularly among women and in iodine-deficient regions. Although most nodules are benign, a significant proportion may be malignant. Ultrasound (US) is the primary imaging tool for evaluation, and the American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) has shown strong performance in risk stratification. This study assessed the diagnostic accuracy of ACR TI-RADS compared with cytological findings at Kilimanjaro Christian Medical Centre.
Methods: A cross-sectional study was conducted among 255 patients who underwent thyroid US and fine-needle aspiration cytology (FNAC) between January 2022 and April 2025. For diagnostic accuracy analysis, Bethesda II–III were grouped as benign, Bethesda IV–VI as malignant, and Bethesda I cases were excluded. ACR TI-RADS categories TR1TR3 were considered low risk (test-negative), while TR4–TR5 were considered high risk (test-positive). Sensitivity, specificity, predictive values, and overall accuracy were calculated, and receiver operating characteristic curve analysis was performed.
Results: The median age was 47 years, and 86.3% of patients were female. Most nodules were mixed cystic/solid (58.8%), hyperechoic (60.4%), wider-than-tall (89.0%), and had smooth margins (67.5%). Based on ACR TI-RADS, 82% of nodules were low risk and 18% high risk. FNAC classified 83.9% as benign, 11% malignant, and 6.3% suspicious. Malignancy rates rose with higher TI-RADS categories, reaching 88% in TR5. ACR TI-RADS demonstrated high diagnostic accuracy with 90.6% sensitivity, 92.6% specificity, and an area under the curve of 0. 951.
Conclusion: ACR TI-RADS is a highly sensitive and specific, non-invasive tool for TN evaluation. While FNAC remains the reference standard, this single-center study suggests TI-RADS has the potential to reduce unnecessary FNACs, particularly in benign nodules. Limitations include reliance on FNAC, single-center design, and operator dependence, which may affect reproducibility.
Publication and Publisher Transfer Disclaimer: This article was originally published by WisdomGale Publishing, having its registered address at 14 Rue de Grand-Bigard, 1082 Brussels, Belgium. Following the formal transfer of publication rights and the subsequent change of publisher, the article was migrated to the publishing platform of International Medical Publishing Group (IMPG), India. The original publication details, authorship, and scholarly content remain unchanged. All subsequent publication management and archival responsibilities are administered by IMPG, India, in accordance with the terms and conditions of the publisher transfer agreement.




